vs
AdvanSix Inc.(ASIX)与UiPath, Inc.(PATH)财务数据对比。点击上方公司名可切换其他公司
UiPath, Inc.的季度营收约是AdvanSix Inc.的1.1倍($411.1M vs $359.9M),UiPath, Inc.净利率更高(48.4% vs -0.8%,领先49.1%),UiPath, Inc.同比增速更快(15.9% vs 9.4%),AdvanSix Inc.自由现金流更多($36.1M vs $25.1M),过去两年AdvanSix Inc.的营收复合增速更高(3.4% vs 0.7%)
AdvanSix Inc.是一家美国化工企业,主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部,于2016年分拆独立,2019年预估营收达14亿美元,其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
UiPath是一家全球化软件企业,专注于开发人工智能、智能自动化及流程编排类软件,其产品支持用户搭建与调度AI代理,实现复杂业务流程、工作流的自动化运行,助力各行业客户提升运营效率、降低人力成本。
ASIX vs PATH — 直观对比
营收规模更大
PATH
是对方的1.1倍
$359.9M
营收增速更快
PATH
高出6.5%
9.4%
净利率更高
PATH
高出49.1%
-0.8%
自由现金流更多
ASIX
多$11.0M
$25.1M
两年增速更快
ASIX
近两年复合增速
0.7%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $359.9M | $411.1M |
| 净利润 | $-2.8M | $198.8M |
| 毛利率 | 7.6% | 83.3% |
| 营业利润率 | -0.7% | 3.2% |
| 净利率 | -0.8% | 48.4% |
| 营收同比 | 9.4% | 15.9% |
| 净利润同比 | -892.9% | 1966.2% |
| 每股收益(稀释后) | $-0.11 | $0.37 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ASIX
PATH
| Q4 25 | $359.9M | $411.1M | ||
| Q3 25 | $374.5M | $361.7M | ||
| Q2 25 | $410.0M | $356.6M | ||
| Q1 25 | $377.8M | $423.6M | ||
| Q4 24 | $329.1M | $354.7M | ||
| Q3 24 | $398.2M | $316.3M | ||
| Q2 24 | $453.5M | $335.1M | ||
| Q1 24 | $336.8M | $405.3M |
净利润
ASIX
PATH
| Q4 25 | $-2.8M | $198.8M | ||
| Q3 25 | $-2.6M | $1.6M | ||
| Q2 25 | $31.4M | $-22.6M | ||
| Q1 25 | $23.3M | $51.8M | ||
| Q4 24 | $352.0K | $-10.7M | ||
| Q3 24 | $22.3M | $-86.1M | ||
| Q2 24 | $38.9M | $-28.7M | ||
| Q1 24 | $-17.4M | $33.9M |
毛利率
ASIX
PATH
| Q4 25 | 7.6% | 83.3% | ||
| Q3 25 | 6.8% | 82.2% | ||
| Q2 25 | 14.3% | 82.1% | ||
| Q1 25 | 14.2% | 84.8% | ||
| Q4 24 | 3.4% | 82.0% | ||
| Q3 24 | 14.4% | 80.0% | ||
| Q2 24 | 17.9% | 83.5% | ||
| Q1 24 | 0.9% | 86.8% |
营业利润率
ASIX
PATH
| Q4 25 | -0.7% | 3.2% | ||
| Q3 25 | -0.9% | -5.6% | ||
| Q2 25 | 7.7% | -4.6% | ||
| Q1 25 | 7.7% | 7.9% | ||
| Q4 24 | -3.9% | -12.2% | ||
| Q3 24 | 7.5% | -32.7% | ||
| Q2 24 | 11.5% | -14.8% | ||
| Q1 24 | -7.0% | 3.7% |
净利率
ASIX
PATH
| Q4 25 | -0.8% | 48.4% | ||
| Q3 25 | -0.7% | 0.4% | ||
| Q2 25 | 7.7% | -6.3% | ||
| Q1 25 | 6.2% | 12.2% | ||
| Q4 24 | 0.1% | -3.0% | ||
| Q3 24 | 5.6% | -27.2% | ||
| Q2 24 | 8.6% | -8.6% | ||
| Q1 24 | -5.2% | 8.4% |
每股收益(稀释后)
ASIX
PATH
| Q4 25 | $-0.11 | $0.37 | ||
| Q3 25 | $-0.10 | $0.00 | ||
| Q2 25 | $1.15 | $-0.04 | ||
| Q1 25 | $0.86 | $0.09 | ||
| Q4 24 | $0.02 | $-0.02 | ||
| Q3 24 | $0.82 | $-0.15 | ||
| Q2 24 | $1.43 | $-0.05 | ||
| Q1 24 | $-0.65 | $0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $1.4B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $815.2M | $1.9B |
| 总资产 | $1.7B | $2.9B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ASIX
PATH
| Q4 25 | $19.8M | $1.4B | ||
| Q3 25 | $23.7M | $1.4B | ||
| Q2 25 | $18.4M | $1.6B | ||
| Q1 25 | $8.3M | $1.6B | ||
| Q4 24 | $19.6M | $1.6B | ||
| Q3 24 | $17.3M | $1.7B | ||
| Q2 24 | $12.1M | $1.9B | ||
| Q1 24 | $20.6M | $1.9B |
股东权益
ASIX
PATH
| Q4 25 | $815.2M | $1.9B | ||
| Q3 25 | $818.2M | $1.7B | ||
| Q2 25 | $823.7M | $1.7B | ||
| Q1 25 | $794.4M | $1.8B | ||
| Q4 24 | $774.6M | $1.7B | ||
| Q3 24 | $766.4M | $1.8B | ||
| Q2 24 | $746.6M | $2.0B | ||
| Q1 24 | $713.2M | $2.0B |
总资产
ASIX
PATH
| Q4 25 | $1.7B | $2.9B | ||
| Q3 25 | $1.7B | $2.6B | ||
| Q2 25 | $1.6B | $2.6B | ||
| Q1 25 | $1.6B | $2.9B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.5B | $2.7B | ||
| Q2 24 | $1.5B | $2.8B | ||
| Q1 24 | $1.5B | $3.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $63.7M | $28.3M |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $25.1M |
| 自由现金流率自由现金流/营收 | 10.0% | 6.1% |
| 资本支出强度资本支出/营收 | 7.7% | 0.8% |
| 现金转化率经营现金流/净利润 | — | 0.14× |
| 过去12个月自由现金流最近4个季度 | $6.4M | — |
8季度趋势,按日历期对齐
经营现金流
ASIX
PATH
| Q4 25 | $63.7M | $28.3M | ||
| Q3 25 | $26.6M | $41.6M | ||
| Q2 25 | $21.1M | $119.0M | ||
| Q1 25 | $11.4M | $146.1M | ||
| Q4 24 | $64.2M | $28.1M | ||
| Q3 24 | $57.3M | $46.4M | ||
| Q2 24 | $50.2M | $100.0M | ||
| Q1 24 | $-36.2M | $145.6M |
自由现金流
ASIX
PATH
| Q4 25 | $36.1M | $25.1M | ||
| Q3 25 | $66.0K | — | ||
| Q2 25 | $-7.2M | $106.2M | ||
| Q1 25 | $-22.6M | $138.7M | ||
| Q4 24 | $29.8M | $23.2M | ||
| Q3 24 | $26.8M | $45.0M | ||
| Q2 24 | $16.7M | $98.8M | ||
| Q1 24 | $-71.6M | $141.8M |
自由现金流率
ASIX
PATH
| Q4 25 | 10.0% | 6.1% | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | -1.7% | 29.8% | ||
| Q1 25 | -6.0% | 32.7% | ||
| Q4 24 | 9.1% | 6.5% | ||
| Q3 24 | 6.7% | 14.2% | ||
| Q2 24 | 3.7% | 29.5% | ||
| Q1 24 | -21.3% | 35.0% |
资本支出强度
ASIX
PATH
| Q4 25 | 7.7% | 0.8% | ||
| Q3 25 | 7.1% | 0.0% | ||
| Q2 25 | 6.9% | 3.6% | ||
| Q1 25 | 9.0% | 1.7% | ||
| Q4 24 | 10.4% | 1.4% | ||
| Q3 24 | 7.7% | 0.4% | ||
| Q2 24 | 7.4% | 0.4% | ||
| Q1 24 | 10.5% | 0.9% |
现金转化率
ASIX
PATH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 26.25× | ||
| Q2 25 | 0.67× | — | ||
| Q1 25 | 0.49× | 2.82× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | — | ||
| Q1 24 | — | 4.29× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
PATH
| Subscription Services | $247.6M | 60% |
| License | $150.0M | 36% |
| Professional Services And Other | $13.5M | 3% |